FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.
What happened
FDA inspected the drug manufacturing facility in Carolina, Puerto Rico, from April 25 to May 6, 2022. Investigators found insects, cobwebs, unexplained spills, a raw-material warehouse partly exposed to the outdoors, and poor cleaning and repair; similar conditions were cited in 2017. FDA also found quality-unit, component-testing and water-system failures.
What FDA found
Hand sanitizers were prepared, packed, or held in insanitary conditions, including insects, cobwebs, spills, and a partly open raw-material warehouse.
FD&C Act section 501(a)(2)(A), 21 U.S.C. 351(a)(2)(A)The quality unit lacked enough people and authority and did not properly oversee or approve investigations.
21 CFR 211.22The company did not test each component lot, including isopropyl alcohol, for identity and did not verify suppliers' certificates of analysis.
21 CFR 211.84(d)(1) and 211.84(d)(2)The water system had design problems such as dead legs, and the company had no validated method for microbiological testing of the water.
21 CFR 211.100(a) and 211.100(b)
What FDA wants
FDA asks the company to correct the violations promptly and respond in writing within 15 working days with corrective actions, including quality-unit fixes, component testing, water-system validation and risk assessment, and an audit by a consultant qualified in current good manufacturing practice (CGMP).
Who should pay attention
- companies that buy or distribute Omega & Delta hand sanitizers
- other drug manufacturers with similar water systems or supplier certificate reliance
- quality teams overseeing hand sanitizer production
This is a summary. Read the original letter on fda.gov.